Literature DB >> 68970

Nature of the antigenic complex recognized by T lymphocytes. IV. Inhibition of antigen-specific T cell proliferation by antibodies to stimulator macrophage Ia antigens.

D W Thomas, U Yamashita, E M Shevach.   

Abstract

We have previously demonstrated that nonimmune guinea pig T lymphocytes could be specifically sensitized with TNP-modified allogeneic macrophages after eliminating the alloreactive T cells with bromodeoxyuridine (BUdR) and light treatment. This procedure allowed the unique opportunity to use anti-Ia sera directed against the Ia antigens of only the stimulator macrophages or responder T cells to determine against which cell type anti-Ia would block TNP-specific stimulation. It was found that the TNP-specific DNA synthetic response of BUdR and light-treated T cells stimulated with TNP-modified allogeneic macrophages was totally eliminated by anti-Ia sera directed solely against the allogeneic stimulator macrophage. In contrast, anti-Ia sera directed only against the responder T cells had no effect on their response to TNP-modified allogeneic macrophages. These findings indicate that macrophage Ia antigens are required for efficient T cell-macrophage interactions and raise the possibility that T cell Ia antigens may not be required for collaboration with macrophages. This latter possibility was substantiated by experiments in which we show that treating T cells with anti-Ia sera and complement to remove the Ia-positive cells either before or after priming, or both, had no effect on their ability to be primed and restimulated with TNP-modified macrophages.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 68970

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Recognition of hapten-modified cells in vitro by human T-lymphocytes.

Authors:  M F Seldin; R R Rich; S L Abramson
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

Review 2.  The role of lymphokines in delayed-type hypersensitivity reactions.

Authors:  C L Geczy
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Genetic control of T-cell proliferative responses to poly(glu40ala60) and poly(glu51lys34tyr15): subregion-specific inhibition of the responses with monoclonal Ia antibodies.

Authors:  C N Baxevanis; D Wernet; Z A Nagy; P H Maurer; J Klein
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

4.  Class II major histocompatibility complex antigen expression on peripheral blood monocytes in patients with inflammatory bowel disease.

Authors:  K R Gardiner; A D Crockard; M I Halliday; B J Rowlands
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

5.  Macrophages migration through the brain parenchyma to the perivascular space following particle ingestion.

Authors:  P E McKeever; J D Balentine
Journal:  Am J Pathol       Date:  1978-10       Impact factor: 4.307

6.  RNA transcripts for I-J polypeptides are apparently not encoded between the I-A and I-E subregions of the murine major histocompatibility complex.

Authors:  M Kronenberg; M Steinmetz; J Kobori; E Kraig; J A Kapp; C W Pierce; C M Sorensen; G Suzuki; T Tada; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

7.  The functional link between the immune suppression gene and Mhc class II molecules.

Authors:  K Mizuno; S Tsuchimoto; Y Matsuno; T Niiyama; H Fujii; T Natori; M Aizawa
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

8.  Monoclonal antibodies to guinea pig Ia antigens. II. Effect on alloantigen-, antigen-, and mitogen-induced T lymphocyte proliferation in vitro.

Authors:  R Burger; E M Shevach
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

9.  The xid gene controls Ia.W39-associated immune response gene function.

Authors:  L J Rosenwasser; B T Huber
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

10.  Anti-Ia antibody in the sera of normal subjects after in vivo antigenic stimulation.

Authors:  K Okudaira; J S Goodwin; R C Williams
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.